187 related articles for article (PubMed ID: 27631392)
1. Exploring the HYDRAtion method for loading siRNA on liposomes: the interplay between stability and biological activity in human undiluted ascites fluid.
Dakwar GR; Braeckmans K; Ceelen W; De Smedt SC; Remaut K
Drug Deliv Transl Res; 2017 Apr; 7(2):241-251. PubMed ID: 27631392
[TBL] [Abstract][Full Text] [Related]
2. Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA.
Li Y; Cheng Q; Jiang Q; Huang Y; Liu H; Zhao Y; Cao W; Ma G; Dai F; Liang X; Liang Z; Zhang X
J Control Release; 2014 Feb; 176():104-14. PubMed ID: 24365128
[TBL] [Abstract][Full Text] [Related]
3. Efficient siRNA delivery using novel siRNA-loaded Bubble liposomes and ultrasound.
Endo-Takahashi Y; Negishi Y; Kato Y; Suzuki R; Maruyama K; Aramaki Y
Int J Pharm; 2012 Jan; 422(1-2):504-9. PubMed ID: 22119963
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.
Taetz S; Bochot A; Surace C; Arpicco S; Renoir JM; Schaefer UF; Marsaud V; Kerdine-Roemer S; Lehr CM; Fattal E
Oligonucleotides; 2009 Jun; 19(2):103-16. PubMed ID: 19374532
[TBL] [Abstract][Full Text] [Related]
5. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
[TBL] [Abstract][Full Text] [Related]
6. PEGylation of lipoplexes: The right balance between cytotoxicity and siRNA effectiveness.
Lechanteur A; Furst T; Evrard B; Delvenne P; Hubert P; Piel G
Eur J Pharm Sci; 2016 Oct; 93():493-503. PubMed ID: 27593989
[TBL] [Abstract][Full Text] [Related]
7. Disregarded Effect of Biological Fluids in siRNA Delivery: Human Ascites Fluid Severely Restricts Cellular Uptake of Nanoparticles.
Dakwar GR; Braeckmans K; Demeester J; Ceelen W; De Smedt SC; Remaut K
ACS Appl Mater Interfaces; 2015 Nov; 7(43):24322-9. PubMed ID: 26470057
[TBL] [Abstract][Full Text] [Related]
8. The biological activity of cationic liposomes in drug delivery and toxicity test in animal models.
Qi P; Cao M; Song L; Chen C; Liu M; Li N; Wu D; Peng J; Hu G; Zhao J
Environ Toxicol Pharmacol; 2016 Oct; 47():159-164. PubMed ID: 27694054
[TBL] [Abstract][Full Text] [Related]
9. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
10. Cationic amphiphilic macromolecule (CAM)-lipid complexes for efficient siRNA gene silencing.
Gu L; Nusblat LM; Tishbi N; Noble SC; Pinson CM; Mintzer E; Roth CM; Uhrich KE
J Control Release; 2014 Jun; 184():28-35. PubMed ID: 24727076
[TBL] [Abstract][Full Text] [Related]
11. Endocytic Transport of Polyplex and Lipoplex siRNA Vectors in HeLa Cells.
Lazebnik M; Keswani RK; Pack DW
Pharm Res; 2016 Dec; 33(12):2999-3011. PubMed ID: 27585903
[TBL] [Abstract][Full Text] [Related]
12. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
13. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
[TBL] [Abstract][Full Text] [Related]
14. Peptide-based targeted polymeric nanoparticles for siRNA delivery.
Hussein WM; Cheong YS; Liu C; Liu G; Begum AA; Attallah MA; Moyle PM; Torchilin VP; Smith R; Toth I
Nanotechnology; 2019 Oct; 30(41):415604. PubMed ID: 31295734
[TBL] [Abstract][Full Text] [Related]
15. Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA.
Bouxsein NF; McAllister CS; Ewert KK; Samuel CE; Safinya CR
Biochemistry; 2007 Apr; 46(16):4785-92. PubMed ID: 17391006
[TBL] [Abstract][Full Text] [Related]
16. Lipopolyplexes comprising imidazole/imidazolium lipophosphoramidate, histidinylated polyethyleneimine and siRNA as efficient formulation for siRNA transfection.
Gonçalves C; Berchel M; Gosselin MP; Malard V; Cheradame H; Jaffrès PA; Guégan P; Pichon C; Midoux P
Int J Pharm; 2014 Jan; 460(1-2):264-72. PubMed ID: 24225347
[TBL] [Abstract][Full Text] [Related]
17. Enhanced cellular uptake and gene silencing activity of siRNA using temperature-responsive polymer-modified liposome.
Wang J; Ayano E; Maitani Y; Kanazawa H
Int J Pharm; 2017 May; 523(1):217-228. PubMed ID: 28330734
[TBL] [Abstract][Full Text] [Related]
18. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
19. Transfection mechanisms of polyplexes, lipoplexes, and stealth liposomes in α₅β₁ integrin bearing DLD-1 colorectal cancer cells.
Adil MM; Erdman ZS; Kokkoli E
Langmuir; 2014 Apr; 30(13):3802-10. PubMed ID: 24635537
[TBL] [Abstract][Full Text] [Related]
20. Optimal combination of cationic lipid and phospholipid in cationic liposomes for gene knockdown in breast cancer cells and mouse lung using siRNA lipoplexes.
Hattori Y; Tang M; Torii S; Tomita K; Sagawa A; Inoue N; Yamagishi R; Ozaki KI
Mol Med Rep; 2022 Aug; 26(2):. PubMed ID: 35686555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
